Trademark Overview
On Monday, January 19, 2026, a trademark application was filed for FILANA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the FILANA THERAPEUTICS trademark a serial number of 99602139. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, January 19, 2026. This trademark is owned by Cassava Sciences, Inc.. The FILANA THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical research services; Scientific research; Providing medical and scientific research information; Medical and scientific research in the field of neurologic and neuropsychiatric disorders including neurodegenerative diseases and developmental disorders, and in the fields of oncologic diseases, metabolic diseases, and pain; Pharmaceutical research and development; Pharmaceutical product evaluation; Technical consulting in the field of pharmaceutical studies; Laboratory research services relating to pharmaceuticals; Testing of pharmaceuticals; Laboratory services for the production of pharmaceuticals in the nature of pharmaceuticals for treating neurologic and neuropsychiatric disorders including neurodegenerative diseases and developmental disorders, and for treating oncologic diseases, metabolic diseases, and pain including analgesic preparations and preparations for pain relief
Pharmaceutical preparations for the treatment of neurologic and neuropsychiatric disorders including neurodegenerative diseases and developmental disorders, and for the treatment of oncologic diseases, metabolic diseases, and pain; Analgesic preparations; Preparation for the relief of pain
Pharmaceutical advice; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing medical information; Providing medical information in the field of neurologic and neuropsychiatric disorders including neurodegenerative diseases and developmental disorders, and in the fields of oncologic diseases, metabolic diseases, and pain